Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.56% is 124% above its 5-year average of -2.38%, near the high end of its 5-year range (-49.89%–5.32%).
5.39% below its 12-month average of 0.59%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-07-31): 5.32%.
OPERATING MARGIN
0.56%
OPERATING MARGIN AVG TTM
0.59%
OPERATING MARGIN AVG 3Y
1.72%
OPERATING MARGIN AVG 5Y
-2.38%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.39%
CURRENT VS 3Y AVG
-67.41%
CURRENT VS 5Y AVG
+123.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$238.16M
Operating Margin
9.95%
TTM Avg
-10.78%
3Y Avg
-18.24%
5Y Avg
-54.36%
Market Cap
$239.35M
Operating Margin
-3996.72%
TTM Avg
-3773.64%
3Y Avg
-4455.47%
5Y Avg
-2970.31%
Market Cap
$237.64M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$237.16M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$235.43M
Operating Margin
28.46%
TTM Avg
31.41%
3Y Avg
33.52%
5Y Avg
34.18%
Market Cap
$241.94M
Operating Margin
N/A
TTM Avg
-7.18%
3Y Avg
-10.59%
5Y Avg
-10.29%
Market Cap
$242.28M
Operating Margin
31.45%
TTM Avg
15.72%
3Y Avg
41.80%
5Y Avg
-775.63%
Market Cap
$234.18M
Operating Margin
25.05%
TTM Avg
37.75%
3Y Avg
43.45%
5Y Avg
51.35%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $238.57M | 0.56% | 0.59% | 1.72% | -2.38% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $238.16M | 9.95% | -10.78% | -18.24% | -54.36% |
| Quantum-Si incorporated (QSI)vs › | $239.35M | -3996.72% | -3773.64% | -4455.47% | -2970.31% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $237.64M | 0.00% | 0.00% | 0.00% | 0.00% |
| Invivyd, Inc. (IVVD)vs › | $237.16M | -103.99% | -400.39% | -200.20% | -133.47% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.43M | 28.46% | 31.41% | 33.52% | 34.18% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | -7.18% | -10.59% | -10.29% |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 31.45% | 15.72% | 41.80% | -775.63% |
| SIGA Technologies, Inc. (SIGA)vs › | $234.18M | 25.05% | 37.75% | 43.45% | 51.35% |
| Century Therapeutics, Inc. (IPSC)vs › | $243.55M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
Gross Margin
25.9%
Operating Margin
0.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-31 | 5.32% |
| 2026-04-30 | 4.52% |
| 2026-01-31 | 2.32% |
| 2025-10-31 | -11.70% |
| 2025-07-31 | 2.50% |
| 2025-04-30 | 0.68% |
| 2025-01-31 | 0.05% |
| 2024-10-31 | -2.05% |
| 2024-07-31 | 2.32% |
| 2024-04-30 | 1.60% |
| 2024-01-31 | 2.18% |
| 2023-12-29 | -26.91% |
| 2023-07-31 | -0.53% |
| 2023-04-30 | -2.24% |
| 2023-01-31 | -3.32% |
| 2022-10-31 | -49.89% |
| 2022-07-31 | -4.90% |
| 2022-04-30 | -9.35% |
| 2022-01-31 | -8.51% |
| 2021-10-31 | -9.01% |
| 2021-07-31 | -15.12% |
| 2021-04-30 | -11.04% |
| 2021-01-31 | -5.34% |
| 2020-10-31 | 2.13% |
| 2020-07-31 | 6.74% |
| 2020-04-30 | 0.76% |
| 2020-01-31 | -15.44% |
| 2019-10-31 | -58.08% |
| 2019-07-31 | -48.72% |
| 2019-04-30 | -65.96% |
| 2019-01-31 | -97.20% |
| 2018-10-31 | -144.90% |
| 2018-07-31 | -32.51% |
| 2018-04-30 | -46.40% |
| 2018-01-31 | 16.97% |
| 2017-10-31 | 12.23% |
| 2017-07-31 | 26.11% |
